z-logo
open-access-imgOpen Access
Rechargeable Stimulators in Deep Brain Stimulation for Obsessive‐Compulsive Disorder: A Prospective Interventional Cohort Study
Author(s) -
De Vloo Philippe,
Raymaekers Simon,
van Kuyck Kris,
Luyten Laura,
Gabriëls Lutgardis,
Nuttin Bart
Publication year - 2018
Publication title -
neuromodulation: technology at the neural interface
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.296
H-Index - 60
eISSN - 1525-1403
pISSN - 1094-7159
DOI - 10.1111/ner.12577
Subject(s) - deep brain stimulation , medicine , prospective cohort study , refractory (planetary science) , population , cohort , movement disorders , psychiatry , surgery , physics , disease , environmental health , astrobiology , parkinson's disease
Background From 1999 onwards, deep brain stimulation (DBS) has been proposed as an alternative to capsulotomy in refractory cases of obsessive‐compulsive disorder (OCD). Although rechargeable implantable pulse generators (rIPGs) have been used extensively in DBS for movement disorders, there are no reports on rIPGs in patients with a psychiatric DBS indication, and even possible objections to their use. Objective We aim to evaluate rIPGs in OCD in terms of effectiveness, applicability, safety, and need for IPG replacement. Methods In this prospective before‐after study recruiting from 2007 until 2012, OCD patients requiring at least one IPG replacement per 18 months were proposed to have a rIPG implanted at the next IPG depletion. OCD severity was the primary outcome. Ten patients were analyzed. Results Psychiatric symptoms and global functioning remained stable in the two years after as compared to the two years before rIPG implantation. Over the same period, the prescribed OCD medication doses did not increase and the DBS stimulation parameters were largely unaltered. Until the end of the follow‐up (mean 4¾ years; maximum seven years), the DBS‐related surgery frequency decreased and there were no rIPG replacements. During the first few weeks after implantation, two patients obsessively checked the rIPG, but afterwards there were no signs of compulsively checking or recharging the rIPG. Two patients experienced rIPG overdischarges (five occurrences in total). Conclusions This is the first report on rIPGs in DBS for OCD patients. The use of rIPGs in this population appears to be effective, applicable, and safe and diminishes the need for IPG replacements.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom